chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Varicella Information has been received from a physician and a school nurse concerning a 8 year old male who on 09-AUG-2000 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck).  It was also noted that the child was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) on 27-AUG-1998 and 07-SEP-2001. A school nurse reported to the physician that between 24-MAR-2005 and 09MAY-2005, the child developed a "more severe case" of chickenpox, noted to be breakthrough with 50 to 250 lesions. Unspecified medical attention was sought. The outcome was recovered. A product quality complaint was not involved. No additional information is expected.
Pt. states that after receiving the 2nd dose of Moderna 07/22/2021, started experiencing symptoms 07/23/2021 of Pericardial, Myocardial, Heart Palpations, and vascular constrictions in both arms. Pain lasting 2 weeks with minor pains still continuing. No Primary visit noted.
28hrs p/vax, t99ax maximum, acted fine, was playing on back dad pulled her to sit up, seemed to go limp, was plae 30-60seconds, whimpered, stared off w/o deviation then cried briefly;fell asleep for 10-15mins then woke up, acted fine
After I got home from work on Friday 1/22 I developed a fever of 100.8 with chills.
burning sensation to the left side of her face; tingling started inside her mouth; tingling started inside her mouth and it was swollen a little; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in the left arm on 02Apr2021 08:30 (Lot Number: ER8733; Expiry date: 31Jul2021) (at the age of 61 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history included blood pressure high from 2015 to an unknown date, Hashimoto's disease (it was unknown how long she has had it, it was diagnosed four months ago, but was not severe enough to need medication), and Bell's palsy from 2018 to an unknown date (about 3 years ago). Concomitant medication included cortisone from Mar2021, for an unspecified indication (given a cortisone shot 3 weeks ago). On 02Apr2021, about 20 to 25 minutes after vaccination, the patient experienced a burning sensation to the left side of her face, then tingling started inside her mouth and it was swollen a little. She says since this morning, she had drunk a lot of water, and it went away, but it came back a little throughout the day, it was not severe and has been less and less each time it comes back. She says she has done no other treatment. The patient was about to be taken to the ER by her husband. She says by then, it started going away so she didn't go. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
The patient had a localized reaction at the injection site, we put ice on the site for 10 minutes. The swelling at the site went down in 10 minutes. No other reaction was noted.
my arm was sore and warm for 5 days; my arm was sore and warm for 5 days; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (got the single dose on an unknown date, before came out with the 2 part vaccine).   On 15-JUL-2023, the patient received the 1st dose of Shingles vaccine. In JUL-2023, less than a week after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: my arm was sore and warm for 5 days) and skin warm (Verbatim: my arm was sore and warm for 5 days). In JUL-2023, the outcome of the pain in arm and skin warm were resolved (duration 5 days).   It was unknown if the reporter considered the pain in arm and skin warm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm and skin warm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 21-JUL-2023 This case was reported by a patient via interactive digital media. The patient asked his/her doctor, should he/she get the 2-part vaccine (better protection) and got 1st dose on Saturday and his/her arm was sore and warm for 5 days. The pharmacy tech warned him/her ahead of time, she stated the 2nd dose was even rougher, but still got to be better than getting shingles. The follow up would not possible as no contact details were available.
Approximately 17 minutes after recieving vaccine his throat became scratchy. On site EMS requested. BP 131/70  HR 63  99% 02 on room air. He refused to go to hospital, released against medical advise.
pain in the right arm that felt like "a thousand needles"; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number 27PA5, expiry date unknown) for prophylaxis.   On 1st August 2021, the patient received the 1st dose of Shingrix. On 8th August 2021, 7 days after receiving Shingrix, the patient experienced pain in arm. On 9th August 2021, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient's wife. The patient received the 1st dose of Shingrix in left arm and 7 day after the vaccination the patient experienced pain in right arm. The reporter stated that  the pain felt like a thousand needles. The reporter stated that patient's pain resolved approximately 12 hours later. The reporter stated that the patient did not receive second dose of Shingrix vaccine yet. The reporter did not consent to follow up.
This spontaneous report was received from a healthcare worker and refers to a multiple unspecified patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. On an unknown date, since 09-AUG-2016, the patients were vaccinated with improperly stored M-M-R II (lot number: K014833, expiry date: 14-SEP-2016, route of administration and therapy type were not reported). Concomitant therapy was not reported. No adverse effect was reported. M-M-R II was exposed to temperature: 48F for 8 hours. There was no previous excursion. It was not specified if, data logger was in use. Additional information has been requested.
After receiving the vaccine, patient passed out with some convulsion activity. We called 911 and while on the call, patient regained his consciousness but was very nauseated and skin was pale. Patient proceeded to throw up a few times and continued to look pale. The police and fire department came. Patient was feeling a better but still pale and nauseous. Patient was then being transported out of the store on a stretcher but not sure where patient is being transported to.
Severe burning central chest pain, EEG with ST elevation,  elevated Troponin at 741, elevated proBNP at 111, elevated CKMB.  Admitted to hospital for telemonitoring on6/4/21, Echocardiogram.  Observed in hospital for 2 days with resolution of symptoms.  Discharged 6/6/21
Rash, swelled, painful, hives at the injection site of upper left arm. Hives on the left arm.
PATIENT WAS NOT SUPPOSED TO RECEIVE MENINGITIS.  MMR WAS ORDERED BUT NURSE GAVE MENINGITIS.  NO KNOWN REACTIONS.
4hr p/vax pt devel sweating & rashes spreading out on face & arms;went to pvt MD & was given anti histamine pill;
This spontaneous report as received from a registered nurse refers to an 18 year old female patient. The patient's pertinent medical history included depression and acne. The patient had no prior history of drug reactions or allergies. On 23-DEC-2014, the patient was vaccinated with the first dose of GARDASIL (lot# K009482, expiry date 06-MAR-2017) (dose and route of administration were not reported). She experienced no adverse effects after she received this first dose. On 26-JUN-2015, the patient was vaccinated with the second dose of GARDASIL (lot# L018286, expiry date 13-APR-2017) intramuscularly in the left deltoid (dose was not reported). Concomitant therapies included WELLBUTRIN, EFFEXOR XR and SEASONALE for contraception. On 26-JUN-2015, 3 hours after vaccination, the patient experienced hives at the injection site. She experienced the hives "on and off" until 08-JUL-2015, when she sought medical attention by being examined by physician. At that time, she had not fully recovered from the event. No treatment was given for the event and no lab diagnostic studies were performed. At the time of this report, the patient did not receive her third dose of GARDASIL. The outcome of the event was unknown. The relatedness between GARDASIL and the event was not provided. Additional information has been requested.
Malaise, painful injection site, mild fever, chills, inability to concentrate. Duration: 24 hours
swelling itching & redness @ site wherre Td was administered sx began 2nd day p/vax given; pt seen 7 days p/vax red, warm, indurated, non-tender patch found @ exam site;
Received Pfizer bivalent, was talking and discussing past side effects. Received flublok then stopped talking. Slumped in chair as if fainting. Intern held patient steady to avoid injury and called for backup. The patient began tensing up and shaking at this point, so pharmacist called EMS while the intern monitored the patient.  He recovered and was responsive, but began to seize again once paramedics began to evaluate him.
This spontaneous report was received from a physician concerning an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # L048236, expiry date: 31-MAR-2018 and lot # M000442, expiry date: 31-MAR-2018, (Strength, dose and route were not reported), which underwent temperature excursions of 31.3 Fahrenheit degrees for 119 hours 15 minutes, 46.5 Fahrenheit degrees for 30 minutes and 30.8 Fahrenheit degrees for 108 hours on unspecified dates. No previous temperature excursions were reported. Data logger was involved. No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient describes about 15 minutes after receiving flumist H1N1 at school she had temp to 105 degrees F. When asked how that was verified she stated her friends felt her to be that hot but teacher would not confirm a fever. She states she simultaneously developed a rash, numb hands, dizziness and nausea. She was brought by her parent to our office (PCP). No meds given. She was afebrile with normal vital signs in no distress and had a normal exam. No discernable rash - patient is fair skinned and has some faint blanching pink macular areas that are difficult to even see. The remainder of exam is normal.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 207L20A) for COVID-19 vaccination.     No reported medical history but consumer takes unspecified heart medications.  The patient's past medical history included No adverse event.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 09Apr2021, the consumer went to an urgent care facility because of  persisting diarrhea .  Laboratory test taken reported everything within normal limits. The consumer was treated with  Imodium and Pepto Bismol. On 14Apr2021, the consumer was seen by his primary physician. On 17Apr2021, the consumer started taking Metamucil. On 20Apr2021, the consumer reported that diarrhea was improving.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient). This 36-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) (Batch/Lot Number: EL9262), dose 1, via an unspecified route of administration in the left arm on 28Jan2021 at 15:30 (at the age of 36-years-old) as 1st DOSE, SINGLE; and BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) (Batch/Lot Number: EN6201), dose 2, via an unspecified route of administration in the left arm on 18Feb2021 at 15:30 (at the age of 36-years-old) as 2nd DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medication were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other unspecified medications within 2 weeks of vaccination. On 22Apr2021 (also reported as 17Apr2021 at 14:00), the patient tested positive for covid 19 after being fully vaccinated. The onset date of the event was reported as 17Apr2021 at 1400. The adverse events resulted in a doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The patient underwent lab tests and procedures which included sars-cov-2 test (PCR) (22Apr2021): positive (Nasal Swab). Clinical outcome of the events tested positive for covid-19 after being fully vaccinated was resolving.
fever 100-101 x 3 days;body aches;nasal congestion;sore throat, lost taste;
Patient with clinical findings consistent with immune thrombocytopenia purpura after receiving COVID-19 vaccination (second dose administered on 4/12/21, presented to emergency department 5/1/21). He presented to the ED with bright red stools, suggestive of GI bleed and a platelet count of 16,000. He was treated with IVIG and is still on a steroid taper with prednisone. He manifested an excellent response to IVIG and prednisone. Overall he appears to be tolerating treatment well - platelets now normalized.
Patient is a 45 year old female with no significant PMHX who presents today high blood pressure, nausea and chills within 30 min of receiving the 1st dose of the COVID-19 vaccine 4 hours ago Denies rash, shortness of breath, vomiting, diarrhea, trouble swallowing or breathing, swelling of throat, tongue, lips or eyes.  No fever. Patient states her BP was taken when she was having the symptoms and it was 170s systolic.  Patient is presenting today with report of nausea, chills and elevated BP s/p COVID-19 vaccine.  Patient has no evidence of anaphylaxis or severe allergic reaction. . Patient has normal vitals and in no respiratory distress. Will discharge home with close outpatient follow-up.
Extremely Swollen and extremely red left elbow; Extremely Swollen and extremely red left elbow; This is a spontaneous report from a non-contactable consumer.   This 76-year-old male patient received the first of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number not provided), via an unknown route in the left arm, on 11Feb2021 12:00 (at the age of 76-year-old) at single dose for COVID-19 immunisation. No relevant medical history was provided. Relevant concomitant medications included methotrexate and calcium folinate (LEUCOVORINE). On 11Feb2021, the patient developed extremely swollen and extremely red left elbow. The events were assessed as non-serious. Both events required emergency room visit. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
The patient experienced fatigue, dizziness, muscle aches in the legs and chest, nausea, night sweats, loss of appetite, loss of weight and stomach cramps.
Pt is a 72 yo male s/p full Moderna COVID vaccination: dose 1 on 2/10/2021 and dose 2 on 3/10/2021. Pt initially presented to the ED on 8/2 for syncopal episode. He was monitored overnight and cardiac echo and carotid Dopplers were completed. At admission he tested positive for COVID and was asymptomatic other than a slight nonproductive cough. Pt received casirivimab/imdevimab infusion on 8/3.
Congestion/ Stopped up nose; Coughing; This spontaneous case was reported by an other health care professional and describes the occurrence of NASAL CONGESTION (Congestion/ Stopped up nose) and COUGH (Coughing) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced NASAL CONGESTION (Congestion/ Stopped up nose) and COUGH (Coughing). At the time of the report, NASAL CONGESTION (Congestion/ Stopped up nose) and COUGH (Coughing) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2022, SARS-CoV-2 test: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.   Reporter did not allow further contact
This spontaneous report as received from a physician refers to a 24 year old female. The patient had no pertinent medical history and drug reactions/allergies. On 08-OCT-2013 the patient was vaccinated with a dose of GARDASIL (lot# 671463/1359AA, expiry date: 23-JUN-2014) (expiry date; 14-JUN-2014 as reported) (dose, location unspecified) intramuscular. No concomitant medication was reported. On 04-NOV-2013, a urine pregnancy test was performed that was positive for pregnancy. The last menstruation period (LMP) was on 14-SEP-2013. The patient's Expected Delivery Date (EDD) was 21-JUN-2014. No known adverse effects. The patient had sought medical attention via went to see the physician. Additional information has been requested.
Hives after 4 month set of imms..  Parents took patient to ER.  ER instructed to tx with Benedryl x 5 days.  No other s/s.
Muffled ear; This is a spontaneous report from a contactable consumer. A male patient (son) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown), dose 1 via an unspecified route of administration on 01Sep2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reporter stated, my son received the vaccination on Wednesday, and he was complaining of like muffled ear on an unspecified date and wanted to know is that a side effect. The clinical outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow-up.
After the second one it got swollen under the right arm.; Started to feel bad; Today is the 4th day and could get out of the bed; Dizzy; Muscle pain; Fever; Chills; Headache; Very very tired/when is making breakfast for the children is like ran 10 kilometers; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Started to feel bad), PERIPHERAL SWELLING (After the second one it got swollen under the right arm.), MOBILITY DECREASED (Today is the 4th day and could get out of the bed), DIZZINESS (Dizzy) and MYALGIA (Muscle pain) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 037C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING ABNORMAL (Started to feel bad). In July 2021, the patient experienced MOBILITY DECREASED (Today is the 4th day and could get out of the bed), DIZZINESS (Dizzy), MYALGIA (Muscle pain), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Very very tired/when is making breakfast for the children is like ran 10 kilometers). On an unknown date, the patient experienced PERIPHERAL SWELLING (After the second one it got swollen under the right arm.). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (Started to feel bad), PERIPHERAL SWELLING (After the second one it got swollen under the right arm.), MOBILITY DECREASED (Today is the 4th day and could get out of the bed), DIZZINESS (Dizzy), MYALGIA (Muscle pain), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Very very tired/when is making breakfast for the children is like ran 10 kilometers) outcome was unknown.            No concomitant products were reported. No treatment medication were reported. The patient stated that she was being told by everyone that symptoms may last for a couple of days.   This case was linked to MOD-2021-260315 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up received on 19-Jul-2021 contains non significant information. On 19-Jul-2021: Follow-up received on 19-Jul-2021 contains non significant information.
7pm, fever of 102.5, gave Tylenol and put her to bed. 12:30 am. fever of 105 degrees Fahrenheit. found in her crib with blue lips, pale face, and having a seizure. eyes rolling to the back of the head and unresponsive for a few minutes. then woke and was in a weird state for the next few hours. crying and no sense of where they were, no eye contact.
Vomited twice 24 hrs post vaccination and then diarrhea for 1 month, (4 times a day). No fever. Also, more irritable and fussy during this time frame.
Mother of Patient states 9mo female received hib vaccine at 9AM on 2/7/14 . Mother noticed patient had a rash on her scalp, back and sides of her body around 8:00 PM 2/7/14. Mother states  vaccine was given left thigh and that injection site had no rash or redness just a slightly raised lump. Mother states patient was acting normal with no trouble breathing.
Starting Sunday 5/7/23, the patient started experiencing severe arm pain in the Right arm only, at the injection site and radiating down into the right armpit. She also had the following symptoms: nausea, fatigue, feeling clammy and lightheaded.  She had to rest the remainder of the day. Currently (5/9/23) the patient is still experiencing severe arm pain when she lifts her arm.  There is no swelling or redness at this time.
Chills, fever of 102, body aches x 2 hrs approx 1 hr after 4th dose. Treated w/Tylenol. Child malled by a stray dog on 4AUG90.  Other doses given 08AUG90, 11AUG, 15AUG.  Also rec'd RIG w/ 1st dose.  Ceclor 375mg q12h.